These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 9151800)

  • 1. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces.
    Arnout J; Wittevrongel C; Vanrusselt M; Hoylaerts M; Vermylen J
    Thromb Haemost; 1998 Jan; 79(1):79-86. PubMed ID: 9459328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding.
    George J; Gilburd B; Hojnik M; Levy Y; Langevitz P; Matsuura E; Koike T; Shoenfeld Y
    J Immunol; 1998 Apr; 160(8):3917-23. PubMed ID: 9558098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
    Yasuda S; Atsumi T; Ieko M; Koike T
    Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J; Meijer P; Vermylen J
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V; Biasiolo A; Rampazzo P; Brocco T
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
    Kandiah DA; Krilis SA
    Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies.
    Subang R; Levine JS; Janoff AS; Davidson SM; Taraschi TF; Koike T; Minchey SR; Whiteside M; Tannenbaum M; Rauch J
    J Autoimmun; 2000 Aug; 15(1):21-32. PubMed ID: 10936025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-interaction of soluble and surface-bound beta2-glycoprotein I and its enhancement by lupus anticoagulants.
    Hayashi A; Hayashi A; Matsuura E; Suzuki K; Koike T; Hashimoto E; Takeya H
    FEBS Lett; 2008 Oct; 582(23-24):3308-12. PubMed ID: 18822289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Ichikawa K; Tsutsumi A; Atsumi T; Matsuura E; Kobayashi S; Hughes GR; Khamashta MA; Koike T
    Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against beta-2-glycoprotein I: use as reference material for lupus anticoagulant tests.
    Arnout J; Vanrusselt M; Wittevrongel C; Vermylen J
    Thromb Haemost; 1998 May; 79(5):955-8. PubMed ID: 9609228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
    Sheng Y; Kandiah DA; Krilis SA
    J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of anti-phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes.
    Levine JS; Subang R; Koh JS; Rauch J
    J Autoimmun; 1998 Oct; 11(5):413-24. PubMed ID: 9802924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulants.
    Arnout J; Vermylen J
    Lupus; 1998; 7 Suppl 2():S23-8. PubMed ID: 9814667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity and immunochemical properties of anti-beta2-glycoprotein I autoantibodies.
    Arvieux J; Regnault V; Hachulla E; Darnige L; Roussel B; Bensa JC
    Thromb Haemost; 1998 Sep; 80(3):393-8. PubMed ID: 9759616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.